abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the recipient of a significant decline in short interest in February. As of February 27th, there was short interest totaling 101,941 shares, a decline of 46.7% from the February 12th total of 191,363 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average trading volume of 260,083 shares, the days-to-cover ratio is currently 0.4 days. Based on an average trading volume of 260,083 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.2% of the company’s stock are short sold.
Hedge Funds Weigh In On abrdn Healthcare Investors
Several institutional investors have recently bought and sold shares of HQH. Uhlmann Price Securities LLC raised its stake in abrdn Healthcare Investors by 3.1% in the fourth quarter. Uhlmann Price Securities LLC now owns 25,711 shares of the financial services provider’s stock worth $487,000 after buying an additional 781 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in abrdn Healthcare Investors by 7.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider’s stock valued at $191,000 after acquiring an additional 788 shares in the last quarter. NewEdge Advisors LLC boosted its position in abrdn Healthcare Investors by 2.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,130 shares of the financial services provider’s stock valued at $684,000 after acquiring an additional 897 shares in the last quarter. Guggenheim Capital LLC increased its holdings in shares of abrdn Healthcare Investors by 2.8% in the 4th quarter. Guggenheim Capital LLC now owns 33,748 shares of the financial services provider’s stock valued at $639,000 after acquiring an additional 929 shares during the period. Finally, Blue Bell Private Wealth Management LLC raised its holdings in abrdn Healthcare Investors by 4.0% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 25,612 shares of the financial services provider’s stock worth $485,000 after purchasing an additional 989 shares in the last quarter. 32.60% of the stock is owned by hedge funds and other institutional investors.
abrdn Healthcare Investors Stock Down 1.9%
abrdn Healthcare Investors stock traded down $0.35 during midday trading on Thursday, hitting $18.25. 163,492 shares of the company’s stock were exchanged, compared to its average volume of 212,208. abrdn Healthcare Investors has a 12 month low of $13.77 and a 12 month high of $20.46. The firm has a 50-day moving average of $19.19 and a two-hundred day moving average of $18.61.
abrdn Healthcare Investors Increases Dividend
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
See Also
- Five stocks we like better than abrdn Healthcare Investors
- Gilder: Don’t Buy AI Stocks, Do This Instead
- “This AI Giant is About to Go Bust”
- The gold chart Wall Street is terrified of…
- Is Iran Just a Giant Smokescreen?
- Warning: You are not moving fast enough
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
